Incidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease
- 31 December 2006
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 4 (12), 1483-1490
- https://doi.org/10.1016/j.cgh.2006.09.019
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Infectious Complications of Percutaneous Vascular Closure DevicesMayo Clinic Proceedings, 2005
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabThe New England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisThe New England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseThe New England Journal of Medicine, 2005
- Varicella–Zoster Virus Vaccine — Grown-ups Need It, TooThe New England Journal of Medicine, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsThe New England Journal of Medicine, 2005
- Preventing Varicella-Zoster DiseaseClinical Microbiology Reviews, 2005
- Epidemiology of varicella-zoster virus in England and WalesJournal of Medical Virology, 2003
- Validity and completeness of the General Practice Research Database for studies of inflammatory bowel diseasePharmacoepidemiology and Drug Safety, 2002
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991